0.38 USD
▼+0.01-2.84%
盘后 0.39 +0.39%
2026-08-03
市值
$15.28M
市盈率
—
EPS
-1.81
股息率
—
52 周区间
0.24 – 2.60
成交量
284.07K
Beta
3.88
目标价
—
52W 低 0.2452W 高 2.60
价格走势
公司简介
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It al...